Amendment to Otsuka-BMS Abilify Agreements Sample Contracts

Confidential Treatment Requested AMENDMENT TO OTSUKA-BMS ABILIFY AGREEMENTS

Amendment to Otsuka-BMS Abilify Agreements • February 15th, 2013 • Bristol Myers Squibb Co • Pharmaceutical preparations

• Contract Type
  Amendment to Otsuka-BMS Abilify Agreements
• Filed
  February 15th, 2013
• Company
  Bristol Myers Squibb Co
• Industry
  Pharmaceutical preparations

THIS AMENDMENT TO OTSUKA-BMS ABILIFY AGREEMENTS (“Amendment”), effective as of October 29, 2012 (“Amendment Effective Date”), is by and between Otsuka Pharmaceutical Co., Ltd. (“Otsuka”), a corporation organized and existing under the laws of Japan, having a principal place of business at Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-Ku, Tokyo, 108-8242 Japan, and Bristol-Myers Squibb Company (“BMS”), a corporation organized and existing under the laws of Delaware, having a principal place of business at Route 206 and Province Line Road, Princeton, New Jersey, 08540, USA. Otsuka and BMS shall be referred to herein individually as a “Party” and collectively as the “Parties.”